Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") (BOLD)

60 filings reported holding BOLD - Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") as of Q1 2025.
Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") (BOLD) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13,012,498 shares of 22,396,688 outstanding shares and own 58% of the company stock.
Largest 10 shareholders include FMR LLC (3,157,772 shares), RA CAPITAL MANAGEMENT, L.P. (2,180,631 shares), Nextech Invest, Ltd. (1,228,069 shares), CITADEL ADVISORS LLC (830,936 shares), Redmile Group, LLC (725,204 shares), SECTORAL ASSET MANAGEMENT INC (678,574 shares), BlackRock, Inc. (628,197 shares), VANGUARD GROUP INC (586,440 shares), WELLINGTON MANAGEMENT GROUP LLP (556,233 shares), and NORTHERN TRUST CORP (315,365 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.